Keros Therapeutics, Inc. KROS
9.73 USD +0.37 (+3.90%)
Nov 9, 2026, 11:21 AM EST
9.31 Day range 9.87
9.26 52-week range 22.55
- YTD
- -52.23%
- 1 year
- -39.97%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 244.06M | 3.55M | 151.00K | 0 | 20.10M | |
| 244.06M | 3.55M | 151.00K | 0 | 20.10M | |
| 67.57M | -210.83M | -169.94M | -114.79M | -56.37M | |
| 87.01M | -187.35M | -152.99M | -104.68M | -58.74M | |
| 2.30 | -5.00 | -5.20 | -4.15 | -2.52 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 288.86M | 561.38M | 332.36M | 280.38M | 231.37M | |
| 338.02M | 615.89M | 370.02M | 306.78M | 255.25M | |
| 34.89M | 44.33M | 37.81M | 29.36M | 12.08M | |
| 16.88M | 18.86M | 14.44M | 13.27M | 1.09M | |
| 303.13M | 571.55M | 332.21M | 277.42M | 243.17M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 107.50M | -160.87M | -124.51M | -70.06M | -62.15M | |
| -1.55M | -1.93M | -2.46M | -1.24M | -1.02M | |
| -378.47M | 391.82M | 178.96M | 120.31M | 28.55M | |
| -1.55M | -1.93M | -2.46M | -1.24M | -1.02M | |
| -272.52M | 229.02M | 51.98M | 49.01M | -34.62M |